Learn More
Medchemexpress LLC Melagatran | 159776-70-2 | 99.3% | 10 MG

Supplier: Medchemexpress LLC HY12905610MG
Melagatran is a reversible, selective, orally active direct inhibitor of thrombin with a Ki of 2 nM. It directly binds to the active site of thrombin, inhibiting the thrombin-mediated conversion of fibrinogen to fibrin. Melagatran reduces the DNA binding activity of NF-κB and AP-1, and has shown to reduce fibrin deposition in organs, alleviate ischemic brain damage, and reduce the size of advanced atherosclerotic lesions.
- Reversible, selective thrombin inhibitor
- Inhibits thrombin-mediated fibrinogen to fibrin conversion
- Reduces DNA binding activity of NF-κB and AP-1
- Alleviates ischemic brain damage
- Decreases advanced atherosclerotic lesion size
- Used in cardiovascular disease research
- Investigated for neurological disease studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.